Dr. Imrana Tanvir
   Breast carcinoma is a leading cause of cancer    death in women.   It is the most common malignant neoplasm, with    ...
   Metastatic adenocarcinomas of unknown origin    makes around 3% of all the cancer patients   It is among the 10 most ...
   Origin of metastatic adenocarcinoma by    morphology alone is difficult.   The primary may be from any of the many   ...
    First identified in the fluid of breast cysts and    in the serum of patients with mammary    carcinomas.   The majo...
   It also inhibits apoptosis by T-cells. It the most    reproducibly present in breast carcinomas    This protein is in...
   Non-neoplastic serous salivary gland acini,    bronchial serous glands, seminal vesicles and    apocrine skin adnexa a...
   To assess the immunohistochemical expression of    GCDFP-15 in Primary Breast Tumors   To compare this expression wit...
SETTING:  Pathology Department of Shaukat Khanum Cancer  Hospital LahoreINCLUSION CRITERIA:Mastectomy specimens from femal...
   50 Mastectomy cases were included          -Tissue from primary tumor          -Tissue from involved lymph nodes.   5...
   Representative sections were taken, processed    and stained with hematoxylin and eosin to see the    tumor morphology.
The immunohistochemical stain GCDFP-15 wasperformed simultaneously in the same batch,according to the specifications given...
   Expression of biomarker (GCDFP-15) in primary    tumors was compared       - With the expression of this biomarker in ...
Intensity of cytoplasmic staining          Negative          Weak          Moderate          Strong% of cytoplasmic st...
Distribution of Cases Accordingto Age       Age of the patients       No. of patients            (Years)                  ...
Distribution of cases according to pathologic characteristics               Pathological characteristics             Findi...
   GCDFP-15 positivity was observed in        - 92% of the primary tumors.        - 88% of metastatic breast carcinomas  ...
   No statistically significant difference of GCDFP-    15 expression was seen between primary and    their respective me...
Sensitivity, specificity and positivepredictive values were calculated byapplying table of 2x2 taking histopathologyas gol...
   These values found in primary tumors were    92% (sn), 84% (sp) and 77.7% (pp)    respectively.   In metastatic tumor...
   Gross cystic disease fluid protein (GCDFP-15) is    a sensitive and a specific marker for detection    of primary and ...
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA
Upcoming SlideShare
Loading in...5
×

COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA

757

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
757
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • also inhibits apoptosis by T-cells. It the most reproducibly present in breast
  • Transcript of "COMPARISON OF GROSS CYSTIC DISEASE FLUID PROTEIN (GCDFP-15) EXPRESSION IN PRIMARY AND METASTATIC BREAST CARCINOMA"

    1. 1. Dr. Imrana Tanvir
    2. 2.  Breast carcinoma is a leading cause of cancer death in women. It is the most common malignant neoplasm, with more than 1,000,000 cases occurring worldwide annually Breast cancer may present as occult primary or as a metastatic lesion.
    3. 3.  Metastatic adenocarcinomas of unknown origin makes around 3% of all the cancer patients It is among the 10 most common malignancies. The prognosis and therapy of the patients with metastatic adenocarcinomas are linked to the site of origin.
    4. 4.  Origin of metastatic adenocarcinoma by morphology alone is difficult. The primary may be from any of the many possible sites, including breast, lung, gastrointestinal tract, endometrium and ovaries. Studies have shown that Gross cystic disease fluid protein 15 (GCDFP-15) is a specific and sensitive marker for breast cancer.
    5. 5.  First identified in the fluid of breast cysts and in the serum of patients with mammary carcinomas. The major constituents in breast cyst fluid being GCDFP-15, GCDFP-24 and GCDFP-44. Encoded on chromosome 7.
    6. 6.  It also inhibits apoptosis by T-cells. It the most reproducibly present in breast carcinomas This protein is induced by prolactin and androgen.
    7. 7.  Non-neoplastic serous salivary gland acini, bronchial serous glands, seminal vesicles and apocrine skin adnexa are immunoreactive. Renal tubules, ovarian surface epithelium and urothelium are negative Staining is cytoplasmic, often with paranuclear enhancement in mammary carcinomas.
    8. 8.  To assess the immunohistochemical expression of GCDFP-15 in Primary Breast Tumors To compare this expression with expression of GCDFP-15 in known Metastatic breast adenocarcinoma Carcinomas. To assess the utility of GCDFP-15 as a diagnostic marker for metastatic breast cancer
    9. 9. SETTING: Pathology Department of Shaukat Khanum Cancer Hospital LahoreINCLUSION CRITERIA:Mastectomy specimens from female patients with primary tumor and corresponding lymph node metastases were included in the study.Control were known cases of adenocarcinoma lung, kidney, colon, endometrium and ovraies.EXCLUSION CRITERIA:The specimens with poorly preserved tumors were excluded.
    10. 10.  50 Mastectomy cases were included -Tissue from primary tumor -Tissue from involved lymph nodes. 50 controls were included from known adenocarcinomas - Lung, ovary, colon endometrium and kidney.
    11. 11.  Representative sections were taken, processed and stained with hematoxylin and eosin to see the tumor morphology.
    12. 12. The immunohistochemical stain GCDFP-15 wasperformed simultaneously in the same batch,according to the specifications given by themanufacturer, on sections made from - Primary breast carcinomas. - Metastatic breast adenocarcinoma in regional axillary lymph nodes from respective mastectomy specimens. - Study Controls
    13. 13.  Expression of biomarker (GCDFP-15) in primary tumors was compared - With the expression of this biomarker in metastatic carcinoma. - On the study controls. 
    14. 14. Intensity of cytoplasmic staining  Negative  Weak  Moderate  Strong% of cytoplasmic staining  Negative: No tumor cell  Focal positive: Less than 10%  Diffusely positive: More than 10%
    15. 15. Distribution of Cases Accordingto Age Age of the patients No. of patients (Years) (%) 20-29 3(6%) 30-39 9(18%) 40-49 16(32%) 50-59 12(24%) 60-69 7(14%) 70-79 3(6%) Mean 47.76years +_SD 13.05 Median 48years Range 21- 76years
    16. 16. Distribution of cases according to pathologic characteristics Pathological characteristics Findings Total no of patients 50 Tumor Size Range 1.0cm to 12.cm Mean 4.44cm +- SD 2.48 Tumor Type Invasive ductal carcinoma (NOS) 47(94%) Invasive lobular carcinoma 3(6%) Lymph node status No of lymph nodes isolated in each case Range 2.0 to 24 Mean 12.62 +_ SD 4.94 No of involved lymph nodes Range 1.0 to 24 Mean 6.14 +- SD 4.40 Size of metastatic deposit Range 0.4cm to 2.2cm Mean 1.2cm +_ SD 0.49
    17. 17.  GCDFP-15 positivity was observed in - 92% of the primary tumors. - 88% of metastatic breast carcinomas (p= 0.000). The concordance value of GCDFP-15 expression between the primary and metastatic tumors was found to be significant i.e. 96%.
    18. 18.  No statistically significant difference of GCDFP- 15 expression was seen between primary and their respective metastatic tumors (p=0.251). All 50 study control cases of adeno- carcinomas were negative for GCDFP-15.
    19. 19. Sensitivity, specificity and positivepredictive values were calculated byapplying table of 2x2 taking histopathologyas gold standard.
    20. 20.  These values found in primary tumors were 92% (sn), 84% (sp) and 77.7% (pp) respectively. In metastatic tumors, these values were 88% (sn), 84% (sp) and 87.7%(pp)respectively. The sensitivity, specificity and predictive values are comparable in both primary and metastatic tumors.
    21. 21.  Gross cystic disease fluid protein (GCDFP-15) is a sensitive and a specific marker for detection of primary and as well as metastatic breast adenocarcinomas. It shows significant concordance between primary and metastatic breast carcinoma to the corresponding lymph nodes. It can be used to identify breast primary in metastatic tumors of unknown origin.

    ×